T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in T2 Biosystems, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −2 vs. Q4 2023
- Shares held
- 173.3K
- −44.8K (−20.6%) vs. Q4 2023
- Total value
- $519.8K
- −$847.9K (−62.0%) vs. Q4 2023
- New holders
- 2
- 5 more added
- Sold out
- 4
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTOO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 2 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 26 | $365.9K |
| Q3 2024 | 21 | $4.24M |
| Q2 2024 | 21 | $12.6M |
| Q1 2024 | 19 | $519.8K |
| Q4 2023 | 21 | $1.37M |
| Q3 2023 | 44 | $4.06M |
| Q2 2023 | 32 | $451.5K |
| Q1 2023 | 34 | $1.55M |
| Q4 2022 | 27 | $667.5K |
| Q3 2022 | 62 | $2.79M |
| Q2 2022 | 68 | $3.07M |
| Q1 2022 | 76 | $7.97M |
| Q4 2021 | 79 | $9.92M |
| Q3 2021 | 79 | $21.1M |
| Q2 2021 | 84 | $33.0M |
| Q1 2021 | 84 | $42.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding T2 Biosystems, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 45,695 | $137.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 41,166 | $123.5K | 0.00% | −13,838−25.2% | Reduced |
| BlackRock Inc. | 36,961 | $110.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 27,840 | $83.5K | 0.00% | +3,786+15.7% | Added |
| Virtu Financial LLC | 13,096 | $39.0K | 0.00% | +3,018+29.9% | Added |
| Tower Research Capital LLC (TRC) | 2,858 | $8.57K | 0.00% | +819+40.2% | Added |
| Group One Trading, L.P. | 2,046 | $6.14K | 0.00% | −1,238−37.7% | Reduced |
| UBS Group AG | 1,750 | $5.25K | 0.00% | +1,750 | New |
| Royal Bank of Canada | 1,384 | $4.00K | 0.00% | +82+6.3% | Added |
| CWM, LLC | 310 | $1.00K | 0.00% | 00.0% | Unchanged |
| Signature Resources Capital Management, LLC | 90 | $565 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 27 | $81 | 0.00% | +5+22.7% | Added |
| Morgan Stanley | 14 | $42 | 0.00% | −106−88.3% | Reduced |
| Newbridge Financial Services Group, Inc. | 10 | $30 | 0.00% | +10 | New |
| Advisor Group Holdings, Inc. | 9 | $27 | 0.00% | −3,000−99.7% | Reduced |
| JJJ Advisors Inc. | 9 | $27 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2 | $6 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | $3 | 0.00% | −106−99.1% | Reduced |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,572−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,417−100.0% | Sold out |
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |